A Study of Risdiplam in Participants With Type I and Type II Spinal Muscle Atrophy (SMA)

Clinical trial NCT07531719 · RECRUITING

Trial details

NCT number: NCT07531719
Sponsor: Hoffmann-La Roche
Status: RECRUITING
Study type: OBSERVATIONAL

Spinal Muscle Atrophy

Start date: 2026-07-22
Primary completion: 2028-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.